111 related articles for article (PubMed ID: 23429390)
1. Evaluation of the response to selective internal radiation therapy in patients with hepatocellular cancer according to pretreatment (99m)Tc-MAA uptake.
Kucuk ON; Soydal C; Araz M; Ozkan E; Aras G
Clin Nucl Med; 2013 Apr; 38(4):252-5. PubMed ID: 23429390
[TBL] [Abstract][Full Text] [Related]
2. Prognostic importance of 18F-FDG uptake pattern of hepatocellular cancer patients who received SIRT.
Kucuk ON; Soydal C; Araz M; Bilgic S; Ibis E
Clin Nucl Med; 2013 Jul; 38(7):e283-9. PubMed ID: 23531737
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
Demirelli S; Erkilic M; Oner AO; Budak ES; Gunduz S; Ozgur O; Bozcuk H; Sindel HT; Boz A
Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137
[TBL] [Abstract][Full Text] [Related]
4. Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients.
Sancho L; Rodriguez-Fraile M; Bilbao JI; Beorlegui Arteta C; Iñarrairaegui M; Moran V; Sangro B
J Vasc Interv Radiol; 2017 Nov; 28(11):1536-1542. PubMed ID: 28916345
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres.
Ulrich G; Dudeck O; Furth C; Ruf J; Grosser OS; Adolf D; Stiebler M; Ricke J; Amthauer H
J Nucl Med; 2013 Apr; 54(4):516-22. PubMed ID: 23447653
[TBL] [Abstract][Full Text] [Related]
6. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
[TBL] [Abstract][Full Text] [Related]
7. Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization.
Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Mar; 56(3):333-8. PubMed ID: 25655623
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT.
Haste P; Tann M; Persohn S; LaRoche T; Aaron V; Mauxion T; Chauhan N; Dreher MR; Johnson MS
J Vasc Interv Radiol; 2017 May; 28(5):722-730.e1. PubMed ID: 28238581
[TBL] [Abstract][Full Text] [Related]
9. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
[TBL] [Abstract][Full Text] [Related]
10. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
[TBL] [Abstract][Full Text] [Related]
11. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment.
Ahmadzadehfar H; Sabet A; Biermann K; Muckle M; Brockmann H; Kuhl C; Wilhelm K; Biersack HJ; Ezziddin S
J Nucl Med; 2010 Aug; 51(8):1206-12. PubMed ID: 20660379
[TBL] [Abstract][Full Text] [Related]
12. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.
Garin E; Lenoir L; Rolland Y; Edeline J; Mesbah H; Laffont S; Porée P; Clément B; Raoul JL; Boucher E
J Nucl Med; 2012 Feb; 53(2):255-63. PubMed ID: 22302962
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of hepatopulmonary shunt obtained from pretherapy 99mTc MAA scintigraphy and post-therapy 90Y Bremsstrahlung imaging in 90Y microsphere therapy.
Jha AK; Zade AA; Rangarajan V; Purandare N; Shah SA; Agrawal A; Kulkarni SS; Shetty N
Nucl Med Commun; 2012 May; 33(5):486-90. PubMed ID: 22395029
[TBL] [Abstract][Full Text] [Related]
14. Characterization of extrahepatic distribution of Tc-99m macroaggregated albumin in hepatic perfusion imaging studies prior to yttrium-90 microsphere therapy.
Jiang M; Nowakowski FS; Wang J; Heiba S; Zhang Z; Weintraub J; Kim E; Machac J
Cancer Biother Radiopharm; 2011 Aug; 26(4):511-8. PubMed ID: 21790309
[TBL] [Abstract][Full Text] [Related]
15. Significance of oral administration of sodium perchlorate in planning liver-directed radioembolization.
Sabet A; Ahmadzadehfar H; Muckle M; Haslerud T; Wilhelm K; Biersack HJ; Ezziddin S
J Nucl Med; 2011 Jul; 52(7):1063-7. PubMed ID: 21680693
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.
Wondergem M; Smits ML; Elschot M; de Jong HW; Verkooijen HM; van den Bosch MA; Nijsen JF; Lam MG
J Nucl Med; 2013 Aug; 54(8):1294-301. PubMed ID: 23749996
[TBL] [Abstract][Full Text] [Related]
17. Quantitative p retreatment VOI analysis of liver metastases. (99m)Tc-MAA SPECT/CT and FDG PET/CT in relation with treatment response to SIRT.
Van de Wiele C; Stellamans K; Brugman E; Mees G; De Spiegeleer B; D'Asseler Y; Beels L; Maes A
Nuklearmedizin; 2013; 52(1):21-7. PubMed ID: 23358716
[TBL] [Abstract][Full Text] [Related]
18. Same-day
Gabr A; Kallini JR; Gates VL; Hickey R; Kulik L; Desai K; Thornburg B; Marshall K; Salzig K; Williams M; Del Castillo C; Ganger D; Hohlastos E; Baker T; Lewandowski RJ; Salem R
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2353-2359. PubMed ID: 27315059
[TBL] [Abstract][Full Text] [Related]
19. Imaging discordance between hepatic angiography versus Tc-99m-MAA SPECT/CT: a case series, technical discussion and clinical implications.
Kao YH; Tan EH; Teo TK; Ng CE; Goh SW
Ann Nucl Med; 2011 Nov; 25(9):669-76. PubMed ID: 21766243
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of 99mTc-MAA- and 99mTc-HSA-Microspheres Used in Preradioembolization Dosimetry: Influence on the Liver-Lung Shunt.
Grosser OS; Ruf J; Kupitz D; Pethe A; Ulrich G; Genseke P; Mohnike K; Pech M; Richter WS; Ricke J; Amthauer H
J Nucl Med; 2016 Jun; 57(6):925-7. PubMed ID: 26912438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]